| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) | 
|---|
| 08/08/1995 | US5440015 Selectin peptide medicaments for treating disease  | 
| 08/08/1995 | US5440013 Conformationally restricted mimetics of beta turns and beta bulges and peptides containing the same  | 
| 08/08/1995 | US5439884 Applying a polypeptide in vitro to stimulate the artificial insemination  | 
| 08/08/1995 | US5439829 Bonding chelating agent to biologically active molecule on a support, treating with oxidizing or reducing agent to change oxidation state of chelating metal ion and immobilize active molecule on the support  | 
| 08/08/1995 | US5439821 A biosynthesized pentapeptides is used as insecticides, antifertility agent of mosquitoes  | 
| 08/08/1995 | US5439820 Anti-thrombin polypeptides  | 
| 08/05/1995 | CA2141907A1 Virus msrvl and pathogen agent and/or msrv2 associated with multiple sclerosis, their nucleic constituants and their applications  | 
| 08/03/1995 | WO1995020764A1 Specific binding substances for antibodies and their use for immunoassays or vaccines  | 
| 08/03/1995 | WO1995020600A1 Immunogens against gonadotropin releasing hormone  | 
| 08/03/1995 | WO1995020599A1 B cell epitope of mite allergen  | 
| 08/03/1995 | WO1995018823A3 Substrate specificity of protein kinases  | 
| 08/03/1995 | DE4402756A1 Spezifische Bindungssubstanzen für Antikörper und deren Verwendung für Immunoassays oder Vakzine Specific binding substances for antibodies and their use for immunoassays or vaccine  | 
| 08/02/1995 | EP0665289A2 Peptides from GAD65, provoking autoimmune reactions  | 
| 08/02/1995 | EP0665215A1 1,4-Diamino-2,3-dihydroxybutanes  | 
| 08/02/1995 | EP0664814A1 Lipopolysaccharide-binding and neutralizing peptides  | 
| 08/02/1995 | EP0664711A1 Peptide inhibitors of cellular adhesion  | 
| 08/02/1995 | EP0489860B1 Methods and compositions for healing ulcers  | 
| 08/02/1995 | CN1106021A Method for the separation of bacterial lipopolysaccharides from protein-containing solutions  | 
| 08/01/1995 | US5438119 Preferential binding of peptide having desired activity or receptivity, then separation from mixed peptides  | 
| 08/01/1995 | US5438118 Peptide mimics having constrained peptide backbone  | 
| 08/01/1995 | US5437982 Methods of identifying specific inactivation gate inhibitors of the sodium channel  | 
| 08/01/1995 | US5437864 Removing blood from patient, administering a monoclonal antibody to neutralization  | 
| 08/01/1995 | CA1336489C Molecular decoyants and methods of use thereof  | 
| 07/26/1995 | EP0663837A1 Prevention of suppression of immune defense against cancer caused by the cancer-associated scm-recognition peptide  | 
| 07/26/1995 | EP0663834A1 Growth hormone releasing peptides  | 
| 07/25/1995 | US5436320 Antibody reagents that identify the carboxy-terminal peptide of the GTP-binding protein Go  | 
| 07/25/1995 | US5436221 Oligopeptides as antitumor agents  | 
| 07/25/1995 | US5436219 Antigrowth agents  | 
| 07/25/1995 | US5436170 Crosslinking  | 
| 07/25/1995 | US5436140 Process for producing WS-9326A and WS-9326B  | 
| 07/25/1995 | US5436137 Promoting fertilization  | 
| 07/25/1995 | US5436127 Epitope-related peptides of human parvovirus  | 
| 07/25/1995 | US5436126 Synthetic peptides specific for the detection of antibodies to HCV, diagnosis of HCV infection and prevention thereof as vaccines  | 
| 07/25/1995 | CA1336404C General cancer-associated scm-recognition factor, preparation and method of use  | 
| 07/21/1995 | CA2140591A1 Antigen-specific, activated t lymphocytes, detection and use  | 
| 07/20/1995 | WO1995019568A1 Hydrophilic signal oligopeptides and methods of therapeutic use  | 
| 07/20/1995 | WO1995019567A1 Synthetic receptors, libraries and uses thereof  | 
| 07/20/1995 | WO1995019436A1 Mammalian monocyte chemoattractant protein receptors  | 
| 07/20/1995 | WO1995019431A1 Zinc finger protein derivatives and methods therefor  | 
| 07/20/1995 | WO1995019372A1 Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof  | 
| 07/20/1995 | WO1995019370A1 Ion-channel forming amphiphilic peptides having n-terminal modifications  | 
| 07/20/1995 | WO1995015335A3 Pretargeting methods and compounds  | 
| 07/20/1995 | CA2210396A1 Method for detection and treatment of breast cancer  | 
| 07/20/1995 | CA2180844A1 Synthetic receptors, libraries and uses thereof  | 
| 07/20/1995 | CA2180748A1 Ion-channel forming amphiphilic peptides having n-terminal modifications  | 
| 07/19/1995 | EP0663404A1 Antibodies for the detection of Salmonella  | 
| 07/19/1995 | EP0424416B1 Acid-labile subunit (als) of insulin-like-growth factor (igf) binding protein complex  | 
| 07/18/1995 | US5434138 Gonadoliberin antagonists  | 
| 07/18/1995 | US5434133 CNP analog peptides and their use  | 
| 07/18/1995 | US5434074 Cytomegalovirus proteinase  | 
| 07/18/1995 | US5434073 Fibrinolytic and anti-thrombotic cleavable dimers  | 
| 07/18/1995 | US5433940 Synthetic molecules mimic action of hirudin by binding to both the low affinity anion-binding exosite and the catalytic site of thrombin  | 
| 07/13/1995 | WO1995018972A1 Systematic modular production of aminimide- and oxazolone-based molecules having selected properties  | 
| 07/13/1995 | WO1995018855A2 Synthetic antimicrobial peptides  | 
| 07/13/1995 | WO1995018823A2 Substrate specificity of protein kinases  | 
| 07/13/1995 | CA2180527A1 Method of making polymers having specific properties  | 
| 07/13/1995 | CA2180526A1 Method of identifying chemical compounds having selected properties for a particular application  | 
| 07/12/1995 | EP0662134A1 Polypeptides involved in streptogramin biosynthesis, nucleotide sequences coding for said polypeptides and use thereof  | 
| 07/12/1995 | EP0662090A1 Peptide inhibitors of mitogenesis and motogenesis  | 
| 07/12/1995 | EP0662083A1 Synthetic peptide vaccine for chlamydia trachomatis  | 
| 07/12/1995 | EP0661999A1 Anti-feline immunodeficiency virus (fiv) vaccines  | 
| 07/12/1995 | EP0661988A1 Composition and treatment with biologically active peptides and chelating agents  | 
| 07/12/1995 | EP0661986A1 Brain-enhanced delivery of neuroactive peptides by sequential metabolism  | 
| 07/12/1995 | EP0661985A1 Cd8 binding domain peptides  | 
| 07/12/1995 | EP0377665B1 Effective antagonists of the luteinizing hormone releasing hormone which release negligible histamine  | 
| 07/11/1995 | US5432260 Polypeptide derivatives of mannose to target glycoprotein receptors on macrophages; asthma; antiinflammatory agents; antitumor agents; immunoassay; imaging  | 
| 07/11/1995 | US5432157 Chrysospermins, active peptides from apiocrea chrysosperma having a pharmacological effect and a use thereof  | 
| 07/06/1995 | WO1995018233A1 Method for detection of methylthioadenosine phosphorylase deficiency in mammalian cells  | 
| 07/06/1995 | WO1995018186A1 Modular design and synthesis of aminimide containing molecules  | 
| 07/06/1995 | WO1995017905A1 Ileal bile acid transporter compositions and methods  | 
| 07/06/1995 | CA2180359A1 Ileal bile acid transporter compositions and methods  | 
| 07/06/1995 | CA2180287A1 T-cell epitopes  | 
| 07/06/1995 | CA2179984A1 Modular design and synthesis of oxazolone-derived molecules  | 
| 07/06/1995 | CA2179983A1 Modular design and synthesis of aminimide containing molecules  | 
| 07/06/1995 | CA2179908A1 Method for detection of methylthioadenosine phosphorylase deficiency in mammalian cells  | 
| 07/05/1995 | EP0661383A2 Method for the determination of thrombocyte aggregation  | 
| 07/05/1995 | EP0661294A1 Cedar pollen protein and uses thereof  | 
| 07/05/1995 | EP0452514B1 Peptide and process for preparing cyclic peptide  | 
| 07/05/1995 | EP0328634B1 Pharmaceutical compositions for the treatment of psoriasis  | 
| 07/05/1995 | CN1104646A Peptides  | 
| 07/04/1995 | US5430018 Cyclohexapeptide with basic nitrogen containing alkylamide groups  | 
| 06/29/1995 | WO1995017678A2 Differentiation of htlv-i and htlv-ii using synthetic peptides  | 
| 06/29/1995 | WO1995017429A1 Monoclonal antibodies specific for phf-tau, hybridomas secreting them, antigen recognition by these antibodies and their applications  | 
| 06/29/1995 | WO1995017423A1 Compounds with growth hormone releasing properties  | 
| 06/29/1995 | WO1995017422A1 Compounds with growth hormone releasing properties  | 
| 06/29/1995 | WO1995017419A1 Metal chelators  | 
| 06/29/1995 | WO1995017412A1 NOVEL HUMAN β2 INTEGRIN ALPHA SUBUNIT  | 
| 06/29/1995 | CA2179598A1 Compounds with growth hormone releasing properties  | 
| 06/29/1995 | CA2179597A1 Compounds with growth hormone releasing properties  | 
| 06/29/1995 | CA2179381A1 Differentiation of htlv-i and htlv-ii using synthetic peptides  | 
| 06/29/1995 | CA2179379A1 Metal chelators  | 
| 06/29/1995 | CA2156622A1 Novel human .beta.2 integrin alpha subunit  | 
| 06/28/1995 | EP0659755A1 Phospholipids as vectors for active molecules, their preparation and their use in cosmetic or dermatologic compositions  | 
| 06/28/1995 | EP0659276A1 Immunoassay for detecting collagen or collagen fragments  | 
| 06/28/1995 | EP0659214A1 Allergenic proteins and peptides from japanese cedar pollen  | 
| 06/28/1995 | EP0432220B1 Vaccines and diagnostic assays for haemophilus influenzae  | 
| 06/28/1995 | CN1104217A Peptides having T cell helper activity  | 
| 06/28/1995 | CA2139014A1 Phospholipids comprising an active molecule, their preparation and their use in cosmetic or dermatologic compositions  | 
| 06/27/1995 | US5428134 Antibody reagents that specifically bind to the carboxyl-terminal decaptide of specific GTP-binding proteins  | 
| 06/27/1995 | US5428129 Peptides and processes for producing cyclic peptides  |